Leptin has been the only known homeostatic regulator of fat mass, but we recently found evidence for a second one, named the gravitostat. In the current study, we compared the effects of leptin and increased loading (gravitostat stimulation) on fat mass in mice with different levels of body weight (lean, overweight, and obese). Leptin infusion suppressed body weight and fat mass in lean mice given normal chow but not in overweight or obese mice given a high-fat diet for 4 and 8 weeks, respectively. The maximum effect of leptin on body weight and fat mass was obtained already at ,44 ng/mL of serum leptin. Increased loading using intraperitoneal capsules with different weights decreased body weight in overweight and obese mice. Although the implantation of an empty capsule reduced the body weight in lean mice, only a nonsignificant tendency of a specific effect of increased loading was observed in the lean mice. These findings demonstrate that the gravitostat regulates fat mass in obese mice, whereas leptin regulates fat mass only in lean mice with low endogenous serum leptin levels. We propose that activation of the gravitostat primarily protects against obesity, whereas low levels of leptin protect against undernutrition. (Endocrinology
Leptin has been the only known homeostatic regulator of fat mass, but we recently found evidence for a second one, named the gravitostat. In the current study, we compared the effects of leptin and increased loading (gravitostat stimulation) on fat mass in mice with different levels of body weight (lean, overweight, and obese). Leptin infusion suppressed body weight and fat mass in lean mice given normal chow but not in overweight or obese mice given a high-fat diet for 4 and 8 weeks, respectively. The maximum effect of leptin on body weight and fat mass was obtained already at ,44 ng/mL of serum leptin. Increased loading using intraperitoneal capsules with different weights decreased body weight in overweight and obese mice. Although the implantation of an empty capsule reduced the body weight in lean mice, only a nonsignificant tendency of a specific effect of increased loading was observed in the lean mice. These findings demonstrate that the gravitostat regulates fat mass in obese mice, whereas leptin regulates fat mass only in lean mice with low endogenous serum leptin levels. We propose that activation of the gravitostat primarily protects against obesity, whereas low levels of leptin protect against undernutrition. (Endocrinology 159: [2676] [2677] [2678] [2679] [2680] [2681] [2682] 2018) O besity is a growing problem worldwide, and it is associated with increased mortality and morbidity (1) . At present, there are few effective pharmacological treatments available for obesity (2) . One possible reason for this is insufficient basic information about the regulation of fat mass. Until recently, the only known homeostatic regulator of fat mass was the fat-derived hormone leptin discovered by Friedman almost a quarter of a century ago (3). The importance of leptin is clear from the finding that genetically caused lack of leptin results in severe obesity that can be reversed by leptin treatment in both experimental animals (4, 5) and humans (6) . In line with this, it has been demonstrated that blockade of endogenous leptin increases body fat mass to the same extent in mice with diet-induced obesity as in lean mice (7) . However, in common obesity, the endogenous serum leptin levels are high, and there is limited effect by leptin treatment. This phenomenon has been referred to as "leptin resistance" (8) (9) (10) (11) . The very modest effect by leptin treatment in obese individuals (12) has limited the clinical use of leptin as an antiobesity drug despite attempts to solve this problem (8, 10, 11, 13) . Since the 1990s, Flier and colleagues [see and Ahima et al. (14) ] have suggested an alternative physiological role for leptin. They found evidence that lack of leptin is a signal that contributes to the response to starvation. Therefore, leptin might regulate fat mass in mice with low fat mass and thereby low endogenous leptin levels.
We have recently published evidence that there is a homeostatic regulation of body weight and fat mass, named the gravitostat (15) , supported by the finding that increased loading using weight capsules decreased body weight and fat mass. Importantly, the gravitostat regulates fat mass independently of fat-derived leptin, revealing two independent negative feedback systems for fat mass regulation (15) . The gravitostat regulates fat mass mainly via altered food intake, but it most likely also to some extent regulates burning to provide energy for an inevitable loading-induced increase in physical workload (15, 16) .
In the current study, we hypothesized that the two known homeostatic regulators of fat mass, leptin and gravitostat, might have different dose-response curves for their effect on body weight and fat mass. We assumed that leptin and the gravitostat are preferentially active in mice with relatively low and high body weight, respectively. To explore this hypothesis, we directly compared the effects of leptin and the gravitostat in mice with different baseline levels of body weight.
Materials and Methods

Animals
All animal procedures were approved by the Ethics Committee on Animal Care and Use in Gothenburg. C57BL/6 male mice, 8 weeks of age, were purchased from Taconic (Ejby, Denmark). The mice were housed in standard conditions: temperature 19°C to 21°C, relative humidity 40% to 70%, and a 12-hour light:12-hour dark cycle, normal daytime. The animals were divided into three different groups with distinct feeding routines in purpose to produce three groups with different body weights: lean, overweight, and obese. Thus, 40 mice were fed normal chow (lean mice; 4% fat; Teklad Global 16% Protein Rodent Diet; Envigo, NJ) ad libitum for 8 weeks, 40 mice were fed normal chow during the initial 4 weeks followed by a high-fat diet ad libitum the last 4 weeks (overweight mice; 60% fat; D12492; Research Diets, New Brunswick, NJ), and the remaining 40 mice were fed the same high-fat diet ad libitum during the whole period of 8 weeks (obese mice). The three different body weight groups (lean: 32.4 6 0.5 g; overweight: 40.2 6 0.4 g; and obese: 47.0 6 0.2 g) were further divided into four subgroups: saline (n = 8), leptin (n = 12), control (n = 10), and load (n = 10). More mice were included in the leptin group than in the saline group in case all pumps would not work properly, but fortunately, no leptin-treated mice needed to be excluded from the experiment.
Leptin and loading treatment
The mice in the saline and leptin subgroups received miniosmotic pumps (Alzet model 2002; Durect, Cupertino, CA) implanted subcutaneously in the neck under isoflurane anesthesia. The mini-osmotic pumps were filled with either saline or leptin (1 mg/g body weight/d; Recombinant Murine Leptin; PeproTech, Rocky Hill, NJ). The mice in the control subgroups received an empty capsule weighing ;3% of the body weight, and the mice in the load subgroups received a capsule filled with tungsten weighing 15% of the body weight implanted intraperitoneally under isoflurane anesthesia. The biological body weight was calculated as the total body weight minus the weight of the capsule, and the change in biological body weight was calculated as the percentage of body weight decrease from the start of treatment.
Tissue dissection and serum analyses
At the end of the experiment, the skeletal gastrocnemius muscle, gonadal white adipose tissue, and retroperitoneal white adipose tissue were dissected and weighed. Blood samples were collected and serum leptin was analyzed in duplicates by a mouse leptin ELISA (Chrystal Chem, Downers Grove, IL).
The effect of loading in relation to baseline body weight in mice on a high-fat diet
The effect of loading in relation to baseline body weight in mice on a high-fat diet was evaluated in 13 independent studies using 3-to 5-month-old male C57BL/6 mice fed a high-fat diet for 3 to 10 weeks, resulting in different baseline body weights (30.4 to 49.0 g). The numbers of mice included in each study, numbered 1 to 13 from the lowest baseline body weight to the highest, were as follows: (1) control (n = 6), load (n = 6); (2) control (n = 4), load (n = 5); (3) control (n = 9), load (n = 10); (4) control (n = 10), load (n = 10); (5) control (n = 10), load (n = 10); (6) control (n = 20), load (n = 20); (7) control (n = 10), load (n = 10); (8) control (n = 6), load (n = 8); (9) control (n = 7), load (n = 9); (10) control (n = 10), load (n = 10); (11) control (n = 10), load (n = 8); (12) control (n = 20), load (n = 20); and (13) control (n = 10), load (n = 10). The loading protocols were identical to the one described above.
Statistics
Data were analyzed using two-tailed Student t test assuming equal variance between saline and leptin groups and between control and heavy load groups. To determine if the effect of increased loading or leptin treatment differed significantly between lean and obese mice, the interaction term from a two-way ANOVA was used. Pearson correlation was used to calculate the correlation between baseline body weight and response to loading. All data are presented as mean 6 SEM.
Results
Leptin treatment reduced the body weight in lean mice (26.7%, P , 0.001) but not in overweight or obese mice compared with saline treatment (Fig. 1A-1C ). In contrast, the body weight-reducing effect of loading was directly correlated with the body weight of the mice. Thus, increased loading decreased the biological body weight compared with controls substantially in obese mice (213.8%, P , 0.001) and moderately in overweight mice (29.2%, P , 0.001), whereas only a nonsignificant tendency of reduced biological body weight was observed by loading in lean mice (24.5%, P = 0.11; Fig. 1D-1F ). The effect of leptin was significantly larger in lean mice than in obese mice (P , 0.01), whereas the effect of loading was significantly larger in obese mice than in lean mice (P , 0.01).
Leptin treatment decreased the weights of the retroperitoneal and gonadal fat depots in lean but not in overweight or obese mice ( Fig. 2A-2C ). In contrast, increased loading decreased the weights of the gonadal (228% 6 4%) and retroperitoneal (240% 6 5%) fat depots substantially and the weight of the gastrocnemius muscle modestly (27% 6 2%; Fig. 2D ) in obese mice. No significant effect of increased loading was observed on the weights of any of these tissues in overweight or lean mice (Fig. 2E and 2F) .
At the end of the experiment, serum leptin levels were measured to verify a functional leptin treatment throughout the whole experiment. The serum leptin levels in the saline-treated lean, overweight, and obese mice were 12, 44, and 80 ng/mL, respectively (Fig. 3A-3C ). Leptin treatment increased the serum leptin levels substantially (fivefold) in lean mice and moderately (twofold) in overweight mice compared with saline treatment (Fig. 3B and 3C ). In contrast, the already high endogenous serum leptin levels were not further increased by leptin treatment in obese mice (Fig. 3A) . Taken together, leptin treatment decreased body weight and fat mass in lean mice with endogenous serum leptin levels of 12 ng/mL. In contrast, leptin had no effect in overweight mice with endogenous serum leptin levels of 44 ng/mL. Moreover, there was no effect of leptin treatment in obese mice that had endogenous serum leptin levels of 80 ng/mL. These findings demonstrate that the maximum effect of leptin on body weight and fat mass is obtained at ,44 ng/mL of serum leptin. Loading reduced serum leptin levels in obese and overweight mice but not in lean mice (Fig. 3D-3F) .
To determine the role of baseline body weight for the loading response in mice on a high-fat diet, we compared the loading response in 13 separate loading experiments with a wide range of baseline body weights (30.4 to 49.0 g). The response to increased loading was given as 100% if the loss in body weight was equal to the increase in loading by the weight of the filled capsule minus the weight of the empty capsule. The average loading response for these 13 experiments was 77.4% 6 6.5%, and the loading response was significant (P , 0.05) in 12 of these 13 separate studies using male C57BL/6 mice on a high-fat diet (Fig. 4A) . Pearson correlation revealed that the loading response was positively correlated with baseline body weight when evaluated for all 13 independent studies (r = 0.62; P , 0.05; Fig. 4A ).
Discussion
The present results showed that increased loading decreased the body weight in mice that were obese or overweight but only marginally in mice that were lean at the start of the experiment. In striking contrast, treatment with leptin suppressed body weight in lean mice but not in overweight or obese mice. Thus, the gravitostat regulates body weight predominantly in obese and overweight mice, whereas leptin regulates body weight only in lean mice with low endogenous serum leptin levels. Leptin is a fat mass-regulating hormone produced in fat tissue in proportion to the fat mass (3). The serum levels of leptin are very high in obese animals (5, 9) and humans (17) , but obviously that has not prevented the development of obesity in these individuals. In line with this, the suppression of body weight by leptin treatment is blunted in mice with diet-induced obesity (18, 19) , and leptin has little effect on common obesity in humans (12) . Based on these results, the term "leptin resistance" has been widely used, although its definition is somewhat controversial (10) . In the current study, we observed that leptin treatment increased serum leptin levels in lean mice, whereas the already very high endogenous leptin levels were not further increased by leptin treatment in obese mice. The maximum effect of leptin on body weight and fat mass was obtained at ,44 ng/mL of serum leptin (Fig. 4B) , which is in line with previous findings from Friedman's group (19) . These findings support prior suggestions that diet-induced obesity results in chronically elevated leptin signaling that cannot be further modulated by additional leptin (19) (20) (21) (22) . Therefore, it is unlikely that leptin alone will become a treatment of large groups of patients with obesity (8, 11) .
As expected, body weight and serum leptin levels, reflecting total body fat mass, were higher in the obese mice compared with the overweight mice. Despite this, no significant increase in the fat mass of the gonadal or retroperitoneal adipose depots was observed in obese mice compared with overweight mice, suggesting that the additional fat in the obese mice compared with the overweight mice was accumulated in other adipose depots and/or in other tissues. Our data, in combination with previous studies, demonstrate that the dose-response curve for the effect of leptin on body weight and fat mass has a steep slope in the lower range of fat mass, resulting in a maximum effect in lean/ slightly overweight subjects (Fig. 4B) . The physiological role of this pattern could be related to the early suggestion that lack of leptin is a signal-initiating response to fasting (14) . More recently, several authors have favored this concept that low leptin is a specific signal for fasting, protecting against undernutrition (8, 11, 23) .
It has been suggested that body fat mass is not controlled in relation to a single set point but to two socalled intervention points, and in between there is a range of fat mass that is acceptable with regard to fitness (24) . Available data summarized above indicate that the lower set point involves reduction of leptin to protect from undernutrition (antifasting signal). However, the nature of the higher set point of importance for fat mass regulation in obese subjects (antiobesity signal) has been unknown (8, 11, 23) . Based on the data in the current study, we propose that the long-sought antiobesity signal acting mainly at a comparatively high body weight involves the gravitostat (15) . This notion is supported by the findings that the effects of increased loading on body weight and fat mass were most pronounced in obese mice (Fig. 4B) . Furthermore, our finding that increased loading exerts only a marginal effect in lean mice given normal chow is in line with earlier minor and inconsistent effects observed in rodents on normal chow (25, 26) .
Similar to what we have noted before, we observed in the current study a body weight loss in mice with abdominal surgery followed by intraperitoneal implantation of an empty capsule (15) . This early body weight loss is substantially less pronounced and of shorter duration in rats compared with mice (15) . We can speculate that it is caused by a combination of (1) the stress of intraperitoneal surgery, (2) the inconvenience of having a big volume of an empty capsule implanted intraperitoneally, and (3) that even the light empty capsule, weighing 2% to 3% of body weight, exerts a small loading effect, slightly contributing to the substantial body weight reduction in mice with the empty capsule. Nevertheless, we see a clear difference in body weight between empty and heavy capsules.
In conclusion, the present findings demonstrate that the gravitostat regulates fat mass in obese mice, whereas leptin regulates fat mass only in lean mice. We propose that activation of the gravitostat primarily protects against obesity (antiobesity signal), whereas low levels of leptin protect against undernutrition (antifasting signal).
